[骨闪烁显像用于观察前列腺癌的病程及治疗]

[Skeletal scintigraphy for the observation of course and treatment of carcinoma of the prostate ].

作者信息

Pabst H W, Langhammer H, Schmid L, Sintermann R

出版信息

Rofo. 1981 Jul;135(1):44-9. doi: 10.1055/s-2008-1056828.

DOI:10.1055/s-2008-1056828

Abstract

Serial skeletal scintigraphy was carried out on 259 patients with carcinoma of the prostate; 5-10% developed bone metastases each year. Isotope uptake was measured in 79 patients receiving treatment; in 60.6% (48 patients) there was a reduction or disappearance of the areas of uptake, in 16.6% (13 patients) they were stationary and 22.8% (18 patients) the metastases progressed. Skeletal scintigraphy is therefore useful during the course of the disease in showing its extent and the effect of treatment.

摘要

对259例前列腺癌患者进行了系列骨骼闪烁扫描；每年有5 - 10%的患者发生骨转移。对79例接受治疗的患者测量了同位素摄取情况；其中60.6%（48例）摄取区域减少或消失，16.6%（13例）保持稳定，22.8%（18例）转移灶进展。因此，骨骼闪烁扫描在疾病过程中对于显示其范围和治疗效果是有用的。